Literature DB >> 24297848

Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.

Timea Kurdiova1, Miroslav Balaz, Marek Vician, Denisa Maderova, Miroslav Vlcek, Ladislav Valkovic, Miroslav Srbecky, Richard Imrich, Olga Kyselovicova, Vitazoslav Belan, Ivan Jelok, Christian Wolfrum, Iwar Klimes, Martin Krssak, Erika Zemkova, Daniela Gasperikova, Jozef Ukropec, Barbara Ukropcova.   

Abstract

Irisin was identified as a myokine secreted by contracting skeletal muscle, possibly mediating some exercise health benefits via 'browning' of white adipose tissue. However, a controversy exists concerning irisin origin, regulation and function in humans. Thus, we have explored Fndc5 gene and irisin protein in two clinical studies: (i) a cross-sectional study (effects of type 2 diabetes (T2D) in drug-naive men) and (ii) an intervention study (exercise effects in sedentary, overweight/obese individuals). Glucose tolerance and insulin sensitivity were assessed. Maximal aerobic capacity and muscle strength were measured before and after training. Body composition (magnetic resonance imaging), muscle and liver fat content (1H-magnetic resonance spectroscopy (MRS)) and in vivo muscle metabolism (32P-MRS) were determined. Skeletal muscle and subcutaneous abdominal adipose tissue samples were taken in the fasted state and during euglycaemic hyperinsulinaemia (adipose tissue) and before/after exercise training (muscle). We found that muscle Fndc5 mRNA was increased in prediabetes but not T2D. Fndc5 in adipose tissue and irisin in plasma were reduced in T2D by 40% and 50%, respectively. In contrast, T2D-derived myotubes expressed/secreted the highest levels of Fndc5/irisin. Neither hyperinsulinaemia (adipose tissue/plasma) nor exercise (muscle/plasma) affected Fndc5/irisin in vivo. Circulating irisin was positively associated with muscle mass, strength and metabolism and negatively with fasting glycaemia. Glucose and palmitate decreased Fndc5 mRNA in myotubes in vitro. We conclude that distinct patterns of Fndc5/irisin in muscle, adipose tissue and circulation, and concordant in vivo down-regulation in T2D, indicate that irisin might distinguish metabolic health and disease. Moreover, Fndc5/irisin was discordantly regulated in diabetic muscle and myotubes in vitro, suggesting that whole body factors, such as glucose and fatty acids, might be important for irisin regulation. Exercise did not affect Fndc5/irisin. However, irisin was positively linked to muscle mass, strength and metabolism, pointing to common regulatory factors and/or the potential for irisin to modify muscle phenotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297848      PMCID: PMC3948565          DOI: 10.1113/jphysiol.2013.264655

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  27 in total

1.  Interrelation of 31P-MRS metabolism measurements in resting and exercised quadriceps muscle of overweight-to-obese sedentary individuals.

Authors:  Ladislav Valkovič; Barbara Ukropcová; Marek Chmelík; Miroslav Baláž; Wolfgang Bogner; Albrecht Ingo Schmid; Ivan Frollo; Erika Zemková; Iwar Klimeš; Jozef Ukropec; Siegfried Trattnig; Martin Krššák
Journal:  NMR Biomed       Date:  2013-08-16       Impact factor: 4.044

2.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.

Authors:  Joo Young Huh; Grigorios Panagiotou; Vassilis Mougios; Mary Brinkoetter; Maria T Vamvini; Benjamin E Schneider; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

3.  Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.

Authors:  José María Moreno-Navarrete; Francisco Ortega; Marta Serrano; Ester Guerra; Gerard Pardo; Francisco Tinahones; Wifredo Ricart; José Manuel Fernández-Real
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

4.  Irisin-immunoreactivity in neural and non-neural cells of the rodent.

Authors:  S L Dun; R-M Lyu; Y-H Chen; J-K Chang; J J Luo; N J Dun
Journal:  Neuroscience       Date:  2013-03-05       Impact factor: 3.590

5.  Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.

Authors:  Andreas Stengel; Tobias Hofmann; Miriam Goebel-Stengel; Ulf Elbelt; Peter Kobelt; Burghard F Klapp
Journal:  Peptides       Date:  2012-12-03       Impact factor: 3.750

6.  Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure.

Authors:  Stewart H Lecker; Alexandra Zavin; Peirang Cao; Ross Arena; Kelly Allsup; Karla M Daniels; Jacob Joseph; P Christian Schulze; Daniel E Forman
Journal:  Circ Heart Fail       Date:  2012-09-20       Impact factor: 8.790

7.  Serum irisin levels in new-onset type 2 diabetes.

Authors:  Yeon-Kyung Choi; Mi-Kyung Kim; Kwi Hyun Bae; Hyun-Ae Seo; Ji-Yun Jeong; Won-Kee Lee; Jung-Guk Kim; In-Kyu Lee; Keun-Gyu Park
Journal:  Diabetes Res Clin Pract       Date:  2013-01-29       Impact factor: 5.602

8.  Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity.

Authors:  Harald Staiger; Anja Böhm; Mika Scheler; Lucia Berti; Jürgen Machann; Fritz Schick; Fausto Machicao; Andreas Fritsche; Norbert Stefan; Cora Weigert; Anna Krook; Hans-Ulrich Häring; Martin Hrabě de Angelis
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

9.  FNDC5/irisin is not only a myokine but also an adipokine.

Authors:  Arturo Roca-Rivada; Cecilia Castelao; Lucía L Senin; María O Landrove; Javier Baltar; Ana Belén Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

10.  Altered response of skeletal muscle to IL-6 in type 2 diabetic patients.

Authors:  Lake Q Jiang; Daniella E Duque-Guimaraes; Ubiratan F Machado; Juleen R Zierath; Anna Krook
Journal:  Diabetes       Date:  2012-10-18       Impact factor: 9.461

View more
  120 in total

1.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

2.  Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry.

Authors:  Mark P Jedrychowski; Christiane D Wrann; Joao A Paulo; Kaitlyn K Gerber; John Szpyt; Matthew M Robinson; K Sreekumaran Nair; Steven P Gygi; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2015-08-13       Impact factor: 27.287

3.  SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise.

Authors:  Joseph P Tiano; Danielle A Springer; Sushil G Rane
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

4.  Impacts of rat hindlimb Fndc5/irisin overexpression on muscle and adipose tissue metabolism.

Authors:  W Farrash; M Brook; H Crossland; B E Phillips; J Cegielski; D J Wilkinson; D Constantin-Teodosiu; P L Greenhaff; K Smith; M Cleasby; P J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-05       Impact factor: 4.310

Review 5.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

6.  Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men.

Authors:  Claire Huth; Marie-Julie Dubois; André Marette; Angelo Tremblay; S John Weisnagel; Michel Lacaille; Pascale Mauriège; Denis R Joanisse
Journal:  J Physiol Biochem       Date:  2015-03-28       Impact factor: 4.158

7.  Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid.

Authors:  A E Huerta; P L Prieto-Hontoria; M Fernández-Galilea; N Sáinz; M Cuervo; J A Martínez; M J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2015-03-28       Impact factor: 4.158

8.  Central and peripheral irisin differentially regulate blood pressure.

Authors:  Weizhen Zhang; Lin Chang; Chao Zhang; Ruthann Zhang; Ziru Li; Biaoxin Chai; Jiyao Li; Eugene Chen; Michael Mulholland
Journal:  Cardiovasc Drugs Ther       Date:  2015-04       Impact factor: 3.727

9.  Fermented goat milk consumption during anaemia recovery: ergogenic effect and improvement of skeletal muscle homeostasis.

Authors:  Jorge Moreno-Fernandez; Javier Diaz-Castro; Mario Pulido-Moran; Maria J M Alferez; Teresa Nestares; Inmaculada Lopez-Aliaga
Journal:  Eur J Nutr       Date:  2016-07-13       Impact factor: 5.614

Review 10.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.